MedTrace Logo

Allosure in Simultaneous Pancreas Kidney Transplant

NCT04777617 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2024-08-07

No results posted yet for this study

Summary

This study will observe donor derived cell free DNA percentages (via the Allosure test) in combined kidney-pancreas transplant recipients to establish both stable and dysfunctional Allosure assay levels

Conditions

  • Kidney Pancreas Transplant

Interventions

OTHER

DD-cfDNA

We are obtaining samples for donor derived cell free DNA in an observational manner. There is no intervention in this study

Sponsors & Collaborators

  • CareDx

    collaborator INDUSTRY

  • University of Texas

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Rowena Delos Santos, MD · Washington University in Saint Louis School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-26
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04777617 on ClinicalTrials.gov